Battling Negative Image Of Generics In Japan (Part 2 of 2)
This article was originally published in PharmAsia News
Executive Summary
[Editor's note: This is part two of a two-part feature on obstacles in promoting generics in Japan. Part one, which explored negative connotations associated with with the term "generic," appeared in PharmAsia News, March 19, 2009.]
You may also be interested in...
Japan's Pharma Companies Should Consolidate, Says Bayer Yakuhin Chairman
TOKYO - Japan's 1,270 pharmaceutical companies should consolidate to look more like the pharma industry in the U.S. or Germany, Bayer Yakuhin Chairman Norikazu Eiki said at the IBC Drug and Biologics conference in Tokyo Feb. 22
Japan's Pharma Companies Should Consolidate, Says Bayer Yakuhin Chairman
TOKYO - Japan's 1,270 pharmaceutical companies should consolidate to look more like the pharma industry in the U.S. or Germany, Bayer Yakuhin Chairman Norikazu Eiki said at the IBC Drug and Biologics conference in Tokyo Feb. 22
Japan Generic Drugs Show Only Minor Quality Problems, Ministry Study Shows
TOKYO - Japan's Ministry of Health, Labor and Welfare found that only two of 876 generic pharmaceutical products investigated showed minor quality problems while conducting a study linked to a national goal of promoting wider generics use